Control group:Standard chemotherapy

4 trials

Sponsors

Shanghai Pulmonary Hospital, Shanghai Public Health Clinical Center Affiliated to Fudan University, Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School

Conditions

Gastric cancerLung Cancercolorectal cancertuberculosis

Phase 2

Individualized treatment of driver gene-negative advanced NSCLC patients with malignant pleural effusions guided by MiniPDX models: a prospective, randomized, open-label, phase II study

Active, not recruitingChiCTR2000037509

Shanghai Pulmonary HospitalLung Cancer

Start: 2020-10-01Updated: 2020-10-19

Phase 4

Individualized chemotherapy for advanced gastric cancer

Active, not recruitingChiCTR-IPR-15006201

Nanjing Drum Tower HospitalGastric cancer

Start: 2015-04-11Updated: 2017-04-18

Multiple routes of palliative chemotherapy for advanced colorectal cancer

RecruitingChiCTR-IPR-16007787

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical Schoolcolorectal cancer

Start: 2016-01-12Updated: 2017-04-18

Unknown Phase

Clinical evaluation of using autologous dendritic cell as adjuvant therapy to poor response tuberculosis: a randomized controlled trial

ChiCTR-INR-16009606

Shanghai Public Health Clinical Center Affiliated to Fudan Universitytuberculosis

Start: 2019-03-27Updated: 2024-04-08

Related Papers

Umbrella strategy with systemic and intraperitoneal chemotherapy versus systemic chemotherapy in patients with advanced gastric cancer: a multicenter, randomized Phase III clinical trial

Clinical Cancer Bulletin2023-12-061 citations

Phase III study of individualized intraperitoneal/intravenous/oral chemotherapy compared with standard intravenous/oral chemotherapy in patients with advanced gastric cancer.

Journal of Clinical Oncology2017-05-20